Search for: "Generic Pharmaceutical Services, Inc."
Results 21 - 40
of 1,031
Sorted by Relevance
|
Sort by Date
29 Oct 2009, 3:30 am
" The Examining Attorney maintained that registrant's services presumably encompass the design and development of pharmaceuticals for others and therefore are related to Applicant's research services. [read post]
8 Feb 2012, 8:43 am
According to DOJ’s press release: Dava Pharmaceuticals Inc. has agreed to pay the United States $11 million to settle allegations that it violated the False Claims Act by misreporting drug prices in order to reduce its Medicaid Drug Rebate obligations, the Justice Department announced today. [read post]
24 Mar 2022, 12:04 pm
Seeking to control branded drug prices, Congress passed the Act to facilitate the entry of generic pharmaceuticals. [read post]
17 Jun 2010, 6:47 am
Abbott Laboratories, Inc. [read post]
7 Jul 2010, 11:10 am
There is no genuine dispute over the sales path generally traversed by Novartis pharmaceuticals. [read post]
4 Dec 2018, 10:34 am
It sought to obtain settlement agreement, licensing agreements and any other related agreements between King Pharmaceuticals , Meridian Technologies, Inc. and Pfizer, Inc., the respondents in the proceeding (collectively, the "Respondents") and Teva Pharmaceutical Industries, Ltd. [read post]
29 Apr 2010, 2:06 am
Regarding the CIA, the Department’s press release said: Also as part of the settlement, Ortho-McNeil-Janssen Pharmaceuticals has agreed to enter into an expansive corporate integrity agreement with the Office of Inspector General of the Department of Health and Human Services. [read post]
5 Jan 2011, 8:54 am
On December 21, 2010, a former employee of drug company, Daiichi Sankyo, Inc. filed a lawsuit alleging that Daiichi misclassified pharmaceutical sales representatives (“Sales Reps”) as exempt employees thereby improperly denying them overtime under the Fair Labor Standards Act (“FLSA”). [read post]
18 Apr 2018, 1:02 pm
In Teva Pharmaceutical USA, Inc. v. [read post]
31 Oct 2011, 12:21 pm
In addition to paying the settlement, DFine has agreed to enter into a corporate integrity agreement with the Office of Inspector General of the Department of Health and Human Services. [read post]
3 May 2016, 9:00 pm
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1] On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
14 Feb 2020, 11:25 am
Patient Services, Inc. [read post]
30 Mar 2012, 7:29 am
("Cypress"), its subsidiary Hawthorn Pharmaceuticals Inc. [read post]
18 Mar 2016, 2:04 pm
Mylan Pharmaceuticals, Inc., 78 F. [read post]
28 May 2013, 12:24 am
Department of Health and Human Services’ Office of Inspector General, ISTA, and B+L will enter into a Divestiture Agreement under which ISTA agrees to be excluded for 15 years, effective six months after the date of the settlement. [read post]
24 Jul 2011, 1:21 pm
Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
2 Sep 2009, 6:40 am
WASHINGTON - American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. [read post]
5 Mar 2015, 5:52 am
Mylan Pharmaceutical, Inc., ___ F. [read post]
15 Sep 2010, 9:30 pm
On September 15, the Department of Justice announced that Forest Pharmaceuticals, Inc. [read post]
10 Aug 2022, 12:00 pm
Biogen Idec, Inc., Civ. [read post]
